<DOC>
	<DOCNO>NCT02477462</DOCNO>
	<brief_summary>Primary biliary cirrhosis ( PBC ) progressive autoimmune disease biliary epithelial cell result biliary cirrhosis . PBC characterize 90 % female predominance , high titer serum anti-mitochondrial autoantibody ( AMA ) direct pyruvate dehydrogenase complex E2 subunit evidence human murine model suggest T-cells , particularly cluster differentiation ( CD ) 8+ T cell , key destruction bile duct . However , clinical trial classic immunosuppressive drug include corticosteroid , azathioprine , methotrexate , tacrolimus largely unsuccessful alter disease course . This single center , prospective , non-treatment study role immune response PBC patient . Non-alcoholic fatty liver disease ( NAFLD ) severe form , non-alcoholic steatohepatitis ( NASH ) common , often `` silent '' liver disease . NASH resemble alcoholic liver disease , occur people drink little alcohol . The major feature NASH fat liver , along inflammation fibrosis . NASH severe lead cirrhosis hepatocellular carcinoma . Ten 20 percent American NAFLD NASH affect 2 5 percent Americans .</brief_summary>
	<brief_title>Identification Inflammatory Fibrotic Biomarkers PBC NAFLD Patients</brief_title>
	<detailed_description>In study , investigator prospectively collect demographic , clinical , laboratory data blood sample research purpose 45 PBC patient 50 male female NAFLD patient . PBC NAFLD diagnosis clinical status evaluate magnetic resonance ( MR ) elastography , transient elastography ( FibroScanÂ® ) blood lab analysis include anti-mitochondrial antibody ( AMA ) , anti-nuclear antibody ( ANA ) , immunoglobulin , complete blood count ( CBC ) , comprehensive metabolic panel ( CMP ) coagulation measure ) . Additionally serum blood obtain patient first visit month 3 , 6 , 9 , 12 , 15 , 18 , 21 &amp; 24 . Serum blood sample use measure serum cytokine abundance transcriptome analysis . For comparison , 95 age ( +/- 5 year ) sex-matched control without PBC recruit clinical laboratory , cytokine , gene expression analysis . Control subject blood drawn single time point .</detailed_description>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<criteria>Inclusion Criteria Primary Biliary Cirrhosis Group : PBC diagnosis base upon least 2 3 criterion : AMA titer &gt; 1:40 ; Alkaline phosphatase &gt; 1.5 time upper limit normal ( ULN ) least 6 month ; Liver biopsy finding consistent PBC 18 year age old . Presence concomitant liver disease include viral hepatitis , primary sclerosing cholangitis ( PSC ) , alcoholic liver disease , Wilson 's disease , hemochromatosis , Gilbert 's syndrome . Prior liver transplantation Use immunosuppressant within 6 month Day 0 , include azathioprine , prednisone , prednisolone , budesonide , cyclosporine , tacrolimus , methotrexate , mycophenolate mofetil . Use biologic agent include anticell anticytokine therapy within 12 month . Inclusion Criteria Control Subjects Absence liver disease inflammatory condition 18 year age old . Exclusion Criteria Control Subjects Presence concomitant liver diseases include PBC , viral hepatitis , PSC , alcoholic liver disease , Wilson 's disease , hemochromatosis , Gilbert 's syndrome . Prior liver transplantation Use immunosuppressant within 6 month , include azathioprine , prednisone , prednisolone , budesonide , cyclosporine , tacrolimus , methotrexate , mycophenolate mofetil . Use biologic agent include anticell anticytokine therapy within 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>